Cristina Whalen Klafehn is the Associate Director of Development Sciences, Patient Advocacy, for the Achondroplasia program at BioMarin. In this role, Cristina aims to identify needs and opportunities to incorporate the patient voice and patient advocacy group perspective across the research and development continuum. Prior to her current role, Cristina served for the past four years as a Health Programs Coordinator in the US Food and Drug Administration’s, Office of Health and Constituent Affairs. In that role, she managed stakeholder engagement on cross-cutting, Agency-wide issues, with a specific focus on pediatric and women’s health. Cristina has a BS in Chemistry from Loyola Marymount University in Los Angeles and a PharmD from the University of Southern California. She is both a board-certified clinical pharmacist and a certified diabetic educator. She has experience providing education and direct pharmaceutical care for patients with complex medical conditions and has run clinics in multiple therapeutic areas for both the Veteran Affairs and Kaiser Permanente medical systems. Cristina has experience providing drug information and safety updates to both patients and providers in her role as a clinical pharmacist and from a regulatory perspective, as a key member of the MedWatch Program, FDA Safety Information and Adverse Event Reporting System. Cristina is based in the BioMarin Washington, D.C office.